Company news
The Oncology Institute, Inc. (NASDAQ:TOI) news
The Oncology Institute, Inc. news releases on 6ix. Latest, Aug 13, 2024: The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full…
Press releases — page 2
The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance
August 12, 2024
The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call
July 22, 2024
The Oncology Institute to Participate at Upcoming Investor Conferences
May 28, 2024
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
May 21, 2024
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
May 13, 2024
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
May 6, 2024
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
April 22, 2024
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
April 7, 2024
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
April 3, 2024
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
March 26, 2024
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
March 13, 2024
The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
March 5, 2024
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
February 19, 2024
WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio
January 24, 2024
The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California
December 3, 2023
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
November 7, 2023
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
October 17, 2023
The Oncology Institute Names Jeremy Castle as Chief Operations Officer
October 10, 2023
The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit
September 25, 2023
The Oncology Institute Regains Compliance with Nasdaq Listing Requirements
September 17, 2023
Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology
August 8, 2023
The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
August 7, 2023
The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations
July 30, 2023
The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call
July 17, 2023
The Oncology Institute Announces Leadership Transition
June 11, 2023
The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research
June 8, 2023
The Oncology Institute to Open Project Southland
June 6, 2023
The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting
May 30, 2023
The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
May 9, 2023
The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education
May 3, 2023
TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer
May 1, 2023
The Oncology Institute Announces First Quarter 2023 Earnings Release Date and Conference Call
April 18, 2023
CORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023
March 15, 2023
The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023
March 8, 2023
The Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference Call
February 15, 2023
The Oncology Institute Expands Into Chino, CA
December 18, 2022
The Oncology Institute Rebrands Clinical Trials Division
December 14, 2022
The Oncology Institute Expands into Miami-Dade County, Hires National Oncology Leader Dr. Roberto Ochoa
November 21, 2022
The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
November 8, 2022
The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference
October 31, 2022
The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call
October 18, 2022
The Oncology Institute Executives to Speak at Key Industry Conferences in Q4
October 16, 2022
The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials
October 10, 2022
The Oncology Institute Expands into South Florida
October 5, 2022
The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib
September 28, 2022
The Oncology Institute Appoints Two New Board Members
September 21, 2022
The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium
September 14, 2022
The Oncology Institute Becomes Certified as a Patient Safety Organization
September 11, 2022
The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms
August 21, 2022
The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day
August 15, 2022